Literature DB >> 14514133

Validating a computerized neuropsychological test battery for mixed ethnic lupus patients.

S L Holliday1, M G Navarrete, D Hermosillo-Romo, C R Valdez, A R Saklad, A Escalante, R L Brey.   

Abstract

Patients with systemic lupus erythematosus (SLE) often show cognitive impairment on traditional neuropsychological tests; however, many of these tests are unsuitable for use with mixed ethnic populations. Computer-administered cognitive tests are promising, but have not been validated against traditional tests or with predominantly Hispanic samples. We gave 67 lupus patients a computer-administered test battery (Automated Neuropsychological Assessment Metrics--ANAM) and a battery of traditional neuropsychological tests. The two batteries were compared using correlation and multiple regression analyses. All patients were fluent in English, 54% were Hispanic and 13% were bilingual. Non-Hispanic patients were predominantly European American (37%). About 80% of patients were rated as impaired on traditional tests. Hispanics were younger, had less education and more current SLE disease activity than non-Hispanics; but did not differ in lifetime SLE-related organ damage or current steroid use. Hispanics and younger patients were more impaired on many of the traditional tests, while ANAM was not affected by Hispanic ethnicity or education. ANAM tests were moderately correlated with analogous traditional tests. Age and selected ANAM scores accounted for about 60% of the variance in the traditional battery. These results replicate the high prevalence of cognitive deficits in SLE found by others and suggest that computer-administered tests like ANAM may be useful for assessment of cognitive impairment in mixed-ethnic samples. Confounding variables such as age, education, English language fluency and prior experience with tests were identified and need to be controlled statistically or with comparison groups in future studies.

Entities:  

Mesh:

Year:  2003        PMID: 14514133     DOI: 10.1191/0961203303lu442oa

Source DB:  PubMed          Journal:  Lupus        ISSN: 0961-2033            Impact factor:   2.911


  15 in total

1.  Anti-NR2 antibodies, blood-brain barrier, and cognitive dysfunction.

Authors:  Gaurav Gulati; Philip H Iffland; Damir Janigro; Bin Zhang; Michael E Luggen
Journal:  Clin Rheumatol       Date:  2016-06-29       Impact factor: 2.980

2.  Validation of the Pediatric Automated Neuropsychological Assessment Metrics in childhood-onset systemic lupus erythematosus.

Authors:  Hermine I Brunner; Marisa S Klein-Gitelman; Frank Zelko; Erin C Thomas; Jessica Hummel; Shannen M Nelson; Jennifer Huggins; Megan L Curran; Tresa Roebuck-Spencer; Dean W Beebe; Jun Ying
Journal:  Arthritis Care Res (Hoboken)       Date:  2013-03       Impact factor: 4.794

3.  Neurocognitive deficits and neuroimaging abnormalities are prevalent in children with lupus: clinical and research experiences at a US pediatric institution.

Authors:  E Muscal; D R Bloom; J V Hunter; B L Myones
Journal:  Lupus       Date:  2009-12-21       Impact factor: 2.911

Review 4.  Challenges of Diagnosing Cognitive Dysfunction With Neuropsychiatric Systemic Lupus Erythematosus in Childhood.

Authors:  Ashwaq AlE'ed; Patricia Vega-Fernandez; Eyal Muscal; Claas H Hinze; Lori B Tucker; Simone Appenzeller; Brigitte Bader-Meunier; Johannes Roth; Vicenç Torrente-Segarra; Marisa S Klein-Gitelman; Deborah M Levy; Tresa Roebuck-Spencer; Hermine I Brunner
Journal:  Arthritis Care Res (Hoboken)       Date:  2017-08-29       Impact factor: 4.794

Review 5.  Neurocognitive impairment in children and adolescents with systemic lupus erythematosus.

Authors:  Deborah M Levy; Stacy P Ardoin; Laura E Schanberg
Journal:  Nat Clin Pract Rheumatol       Date:  2009-02

6.  Non-criteria anti-phospholipid antibodies and cognitive impairment in SLE.

Authors:  Michael E Luggen; Gaurav Gulati; Bin Zhang; Rohan A Willis; Emilio B Gonzalez
Journal:  Clin Rheumatol       Date:  2015-11-12       Impact factor: 2.980

7.  Assessment of cognitive function in systemic lupus erythematosus, rheumatoid arthritis, and multiple sclerosis by computerized neuropsychological tests.

Authors:  John G Hanly; Antonina Omisade; Li Su; Vernon Farewell; John D Fisk
Journal:  Arthritis Rheum       Date:  2010-05

8.  Comparison of cognitive functions between people with silent and wild-type butyrylcholinesterase.

Authors:  I Manoharan; A Kuznetsova; J D Fisk; R Boopathy; O Lockridge; S Darvesh
Journal:  J Neural Transm (Vienna)       Date:  2007-02-22       Impact factor: 3.850

Review 9.  Anti-NR2A/B Antibodies and Other Major Molecular Mechanisms in the Pathogenesis of Cognitive Dysfunction in Systemic Lupus Erythematosus.

Authors:  Sen Hee Tay; Anselm Mak
Journal:  Int J Mol Sci       Date:  2015-05-06       Impact factor: 5.923

10.  25-Hydroxyvitamin D3 Deficiency Independently Predicts Cognitive Impairment in Patients with Systemic Lupus Erythematosus.

Authors:  Sen Hee Tay; Chung Shun Ho; Roger Chun-Man Ho; Anselm Mak
Journal:  PLoS One       Date:  2015-12-04       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.